Abstract
Post-hepatitis cirrhosis (PHC), which results from either hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, and its associated with hemodynamic changes may cause the spleen to become functionally hyperactive—a condition known as hypersplenism. Hypersplenism is associated with anemia, leukopenia, thrombocytopenia and splenomegaly. There are several effective methods to treat hypersplenism with the development of medical technology and the main purpose is the remission of hypersplenism, reducing the portal hypertension and decreasing the risk of hemorrhage. However, complete splenectomy or partial treatment of the hyperactive spleen is still controversial all over the world. This may be caused by the lack of the knowledge on the pathophysiological characteristics and clinical significance of treating hypersplenism. This review is a comprehensive discussion on the recent research which investigates hypersplenism caused by PHC. Key words: Cirrhosis; Hypersplenism; Pathophysiology; Treatment
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
